MSNews updates are on hold until further notice. Sign-up on our mailing list here to be notified when we are back.
MS trial outcome measures are insufficient
Submitted by art on Wed, 2008-10-08 06:43.
These researchers conclude that measures of unremitting disability used in trials of relapsing-remitting multiple sclerosis cannot be validated. Trials have been too short or degrees of disability change too small to measure the key outcomes. These analyses highlight the difficulty in determining effectiveness of therapy in chronic diseases.
Yet more fuel for the fire that says we need proper biological markers of disease progression - something we believe our repository can help establish.